Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

IL-7 is an important cytokine for T cell lymphopoiesis. Blockade of the IL-7 signaling pathway has been shown to induce long-term graft survival or graft tolerance in murine transplant models through inhibiting T cell homeostasis and favoring immunoregulation. In this study, we assessed for the first time the effects of a blocking anti-human cluster of differentiation 127 (CD127) mAb administered in combination with low-dose tacrolimus or thymoglobulin in a life-sustaining kidney allograft model in baboons. Contrary to our expectation, the addition of an anti-CD127 mAb to the treatment protocols did not prolong graft survival compared to low-dose tacrolimus alone or thymoglobulin alone. Anti-CD127 mAb administration led to full CD127 receptor occupancy during the follow-up period. However, all treated animals lost their kidney graft between 1 week and 2 weeks after transplantation. Unlike in rodents, in nonhuman primates, anti-CD127 mAb treatment does not decrease the absolute numbers of lymphocyte and lymphocyte subsets and does not effectively inhibit postdepletional T cell proliferation and homeostasis, suggesting that IL-7 is not a limiting factor for T cell homeostasis in primates. © 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.


Hoa Le Mai, Thi Van Ha Nguyen, Julien Branchereau, Nicolas Poirier, Karine Renaudin, Caroline Mary, Lyssia Belarif, David Minault, Jeremy Hervouet, Stéphanie Le Bas-Berdardet, Jean-Paul Soulillou, Bernard Vanhove, Gilles Blancho, Sophie Brouard. Interleukin-7 receptor blockade by an anti-CD127 monoclonal antibody in nonhuman primate kidney transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2020 Jan;20(1):101-111

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 31344323

View Full Text